Association between frequent cardiac resynchronization therapy optimization and long-term clinical response: A post hoc analysis of the Clinical Evaluation on Advanced Resynchronization (CLEAR) pilot study

Europace

Volumn 15, Issue 8, 2013, Pages 1174-1181

  Delnoy, Peter Paul ^a   Ritter, Philippe ^b   Naegele, Herbert ^c   Orazi, Serafino ^d   Szwed, Hanna ^e   Zupan, Igor ^f   Goscinska Bis, Kinga ^g   Anselme, Frederic ^h   Martino, Maria ⁱ   Padeletti, Luigi ^j  

^a ISALA HOSPITAL   (Netherlands)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c Schlaflabor St Adolf Stift   (Germany)

^d PO S Camillo De Lellis   (Italy)

^e INSTITUTE OF CARDIOLOGY   (Poland)

^f UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^g Department of Electrocardiology ^*  (Poland)

^h ROUEN UNIVERSITY HOSPITAL   (France)

ⁱ Cyberonics Inc   (Italy)

^j CAREGGI UNIVERSITY HOSPITAL   (Italy)

more..

Author keywords

Atrioventricular delay; Cardiac resynchronization therapy optimization frequency; Echocardiography; Interventricular delay; Long term clinical response; SonR

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEATH; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

EID: 84880959599     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut034     Document Type: Article

References (23)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33: 1787-847. Epub 2012 May 19
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53
3. Saxon LA, Boehmer JP, Hummel J, Kacet S, De Marco T, Naccarelli G et al. Biventricular pacing in patients with congestive heart failure: Two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. Am J Cardiol 1999;83:120D-3D.
4. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. for the Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003;289:2685-94
5. Adelstein EC, Shalaby A, Saba S. Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency. Pacing Clin Electrophysiol 2010;33: 850-9
6. Bleeker GB, Schalij MJ, Van derWall EE, Bax JJ. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17:899-901
7. Ansalone G, Giannantoni P, Ricci R, Trambaiolo P, Fedele F, Santini M. Doppler myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving myocardial imaging to evaluate the effectiveness of pacing sites in patients receiving biventricular pacing. J Am Coll Cardiol 2002;39:489-99
8. Antonini L, Auriti A, Pasceri V, Meo A, Pristipino C, Varveri C et al. Optimization of the atrioventricular delay in sequential and biventricular pacing: Physiological bases, critical review, and new purposes. Europace 2012;14:929-38
9. Porciani MC, Dondina C, Macioce R, Demarchi G, Pieragnoli P, Musilli N et al. Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol 2005;95:1108-10
10. O'Donnell D, Nadurata V, Hamer A, Kertes P, MohamedW. Long-Term variations in optimal programming of cardiac resynchronization therapy devices. Pacing Clin Electrophysiol 2005;28(Suppl 1):24-6
11. Gras D, Gupta MS, Boulogne E, Guzzo L, Abraham WT. Optimization of AV and VV delays in the real-world CRT patient population: An international survey on current clinical practice. Pacing Clin Electrophysiol 2009;32(Suppl 1):S236-9
12. Delnoy PP, Marcelli E, Oudeluttikhuis H, Nicastia D, Renesto F, Cercenelli L et al. Validation of a peak endocardial acceleration-based algorithm to optimize cardiac resynchronization: Early clinical results. Europace 2008;10:801-8
13. Cuoco FA, Gold MR. Optimization of cardiac resynchronization therapy: Importance of programmed parameters. J Cardiovasc Electrophysiol 2012; 23:110-8
14. Abraham WT, Gras D, Yu CM, Calo L, Islam N, Klein N et al. Results from the FREEDOM trial: Assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy. Presented at Heart Rhythm Society 31st Annual Scientific Sessions Denver, CO, 2010, Abstract SP08
15. Ellenbogen KA, Gold MR, Meyer TE, Lozano IF, Mittal S, Waggoner AD et al. Primary results from the SmartDelay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiographyguided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010;122:2660-8
16. Ritter P, Delnoy PP, Padeletti L, Lunati M, Naegele H, Borri-Brunetto A et al. randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace 2012;14:1324-33
17. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M et al. Task force for the diagnosis and treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: Full text. Eur Heart J 2005;26(11):1115-40
18. EuroQol Group. EuroQol-A new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208
19. Mullens W, Grimm RA, Verga T, Dresing T, Starling RC, Wilkoff BL et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. JACC 2009;53:765-73
20. Zhang Q, Wing-Hong Fung J, Chan YS, Chi-Kin Chan H, Lin H, Chan S et al. The role of repeating optimization of atrioventricular interval during interim and longterm follow-Up after cardiac resynchronization therapy. Int J Cardiol 2008;124: 211-7
21. Brenyo AJ, Tompkins C, Moss A, Barsheshet A, Rao M, Huang DT et al. Atrioventricular delay and the risk of heart failure and death in MADIT-CRT. Heart Rhythm 2012;9(Suppl 5S):65
22. Foley PW, Leyva F, Frenneaux MP. What is treatment success in cardiac resynchronization therapy? Europace 2009;11(Suppl 5):v58-65
23. Delnoy PP, Lunati M, Nagele H, Padeletti L, Silvestre J, Martino M et al. Periodic VV and AV delays optimization in cardiac resynchronization therapy improves patients' clinical outcome: Results from the CLEAR study. Heart Rhythm 2010; 7(5S):55